LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 345 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.67 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $386,000 | +70.8% | 3,074 | +84.6% | 0.01% | +75.0% |
| Q4 2018 | $226,000 | -65.3% | 1,665 | -29.9% | 0.00% | -66.7% |
| Q3 2018 | $652,000 | +18.3% | 2,375 | -10.7% | 0.01% | +9.1% |
| Q2 2018 | $551,000 | +25.2% | 2,661 | -0.0% | 0.01% | +22.2% |
| Q1 2018 | $440,000 | +21.5% | 2,662 | +0.6% | 0.01% | +12.5% |
| Q4 2017 | $362,000 | -2.4% | 2,647 | -3.0% | 0.01% | +14.3% |
| Q3 2017 | $371,000 | +172.8% | 2,730 | +142.2% | 0.01% | +133.3% |
| Q2 2017 | $136,000 | +11.5% | 1,127 | -2.3% | 0.00% | 0.0% |
| Q1 2017 | $122,000 | -27.4% | 1,153 | -31.0% | 0.00% | -25.0% |
| Q4 2016 | $168,000 | -3.4% | 1,670 | -3.0% | 0.00% | 0.0% |
| Q3 2016 | $174,000 | -13.0% | 1,722 | +2.4% | 0.00% | -33.3% |
| Q2 2016 | $200,000 | – | 1,682 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $6,891 | 2.63% |
| VILLERE ST DENIS J & CO LLC | 438,161 | $26,254,607 | 2.24% |
| RICE HALL JAMES & ASSOCIATES, LLC | 282,961 | $16,955,023 | 1.08% |
| Chicago Capital, LLC | 360,345 | $21,591,884 | 1.01% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 206,399 | $12,367,428 | 0.53% |
| Smith, Graham & Co., Investment Advisors, LP | 61,849 | $3,705,992 | 0.46% |
| Stephens Investment Management Group LLC | 467,564 | $28,016,435 | 0.46% |
| Jackson Creek Investment Advisors LLC | 13,657 | $818 | 0.34% |
| Court Place Advisors, LLC | 15,133 | $906,769 | 0.32% |
| Ziegler Capital Management, LLC | 123,158 | $7,379,176 | 0.30% |